Follow The Filings

KINS Kingstone Companies

Kingstone Companies earnings company data as of 7:50 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.87 — —
Rev — — —

Insider trades

Open-market buys and sales by KINS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KINS insider trades
  • $653K bought by 1 insider
  • None no sales outside a trading plan
  • $243K sold by 1 insider under 10b5-1 plans
  1. Thomas Newgarden Director
    Buy
    $213K 14,000 shares at $15.21 +16% to stake
    Traded May 28–29 Filed Jun 1
    ↗
  2. Thomas Newgarden Director
    Buy
    $440K 30,502 shares at $14.44 +56% to stake
    Traded May 12–13 Filed May 13
    ↗
  3. William L Yankus Director
    Planned sale
    $243K 13,500 shares at $18.00 14% of stake
    Traded Apr 16 Filed Apr 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 10 stock grants, 7 share withholdings for taxes, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 4.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,7.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
DEF 14A Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13D — Filing Doc
8-K 2.02,7.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 8 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.